Medtronic Canada Named Top 50 Great Places To Work and Best Workplaces for Women

Reinforces Medtronic's Commitment to Diversity
and Empowering Women to Lead at All Levels

 Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the world's largest medical technology, services, and solutions company — has been named on the 2021 lists of Top 50 Great Places to Work in Canada and Best Workplaces™ for Women for the second consecutive year after a thorough and independent analysis conducted by Great Place to Work®.

Medtronic Canada recognized among Best Workplaces for Women 2021 (CNW Group/Medtronic Canada ULC)

"Our Mission has always been the mainstay of our identity — to contribute to human welfare," said Yvonne Farquharson , director of Human Resources, Medtronic Canada. "In this past year, tenet five of the Medtronic Mission, which reinforces the personal worth of all employees, has been especially resonant. We have focused on employee's health and safety, staying connected virtually, and fostering a workplace where everyone can thrive."

Medtronic has always strived to maintain a sense of connection among employees, especially since pivoting to a remote work model for most employees. This has been addressed through various initiatives, including bi-weekly virtual all-employee meetings.

In these meetings, employees have rallied together to support and learn from each other. The calls have featured guest speakers, including a diversity and inclusion advocate who facilitated a meaningful conversation about anti-racism.

Diversity and inclusion have been an important focus at Medtronic for many years. Medtronic has a strong foundation with active employee resource groups, networking circles and development programs. The efforts by Medtronic to advance women has earned the esteemed Catalyst recognition in 2020. At Medtronic Canada, women account for over 50% of all employees and 55% of the Canadian Leadership Team.

"The importance of fostering a diverse workforce and supporting our women colleagues at all levels is ingrained in our organization's culture," shares Neil Fraser , president of Medtronic Canada. "Having an inclusive, diverse and equitable environment leads to innovation, which enables us to continue providing life-saving technology to people all around the world."

Organizations on these lists must be Great Place to Work-Certified™ in the past year, headquartered in Canada and at least 90% of employees must agree that people are treated fairly, regardless of their gender. Recognition on these two lists is one of many honours Medtronic Canada has received over the past year.

Medtronic was recognized by Forbes as one of Canada's Best Employers in January 2021 , and in 2020, was ranked as among Canada's Top 100 Employers and the GTA's top employers by Media Corp. It was also ranked one of Canada's Best Workplaces in Healthcare , one of the Best Workplaces for Mental Wellness in Canada , and one of the Best Workplaces in Ontario by the Great Place to Work Institute of Canada .

Medtronic is the largest medical device employer in Canada , with over 1,100 employees. In 2020 alone, Medtronic innovation and technology benefitted 75 million people globally — that's two people every second.

About Great Place to Work®
Great Place to Work is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, GPTW recognizes the world's Best Workplaces in a series of national lists including those published by The Globe & Mail ( Canada ) and Fortune magazine ( USA ). Great Place to Work provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. Visit us at www.greatplacetowork.ca

About Medtronic Canada ULC
Proudly serving Canadian healthcare for over 50 years, Medtronic Canada ULC ( www.medtronic.ca ) is a subsidiary of Medtronic plc, the world's largest medical technology, services, and solutions companies — alleviating pain, restoring health, and extending life for millions of people around the world. Serving physicians, hospitals, and patients across the country, Medtronic Canada ULC is headquartered in Brampton, Ontario , with regional offices in Montreal and Vancouver , and a Medtronic Resource Centre in Surrey, BC . The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the U.S. Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Medtronic Logo (CNW Group/Medtronic Canada ULC)

SOURCE Medtronic Canada ULC

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/April2021/14/c4243.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)

Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024, at 10:30 a.m. ET at the Metro Toronto Convention Centre in Toronto. A copy of the presentation will be available at www.knighttx.com .

About Knight Therapeutics Inc.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

New Documentary Released by Medtronic: "A Voice for Health"

Join us on a journey to Kenya and discover how Medtronic LABS is expanding access to essential healthcare.

Yesterday was World Health Day, and the theme this year is ‘My health, my right'. Over half the world's population can't access essential health services. The mission of Medtronic LABS is to change that. Watch as the team travels to Kenya to capture the everyday stories from people who utilize LABS' technology to better track their health

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation

EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical trial safety and efficacy results for Sphere-360™, an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy, for treatment of patients with paroxysmal atrial fibrillation (AFib). Interim findings from the first-in-human Sphere-360 study were presented as a late-breaking clinical trial at the European Heart Rhythm Association (EHRA) 2024 Annual Meeting .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

SMART trial one-year data demonstrates Medtronic Evolut TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women

New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien™ at one year

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), were presented as a late breaking clinical trial at the American College of Cardiology Annual Scientific Session and simultaneously published in The New England Journal of Medicine . The one-year results of the SM all A nnuli R andomized T o Evolut or SAPIEN (SMART) Trial in individuals with aortic stenosis (AS) with small aortic annuli (SAA) demonstrated noninferior clinical outcomes and superior valve performance as measured by bioprosthetic valve dysfunction performance for the Evolut™ TAVR platform compared to the SAPIEN™ platform.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

New survey uncovers lack of awareness around heart valve disease and risk factors among women

Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease

Medtronic plc, a global leader in healthcare technology, today unveiled topline findings of its comprehensive survey on women's perceptions and knowledge of risk factors, treatment patterns, and preventive care practices related to heart valve disease. The survey is endorsed by Women as One and was conducted by Wakefield Research sampling 1,000 women in the United States (U.S.) aged 50 and older.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for UCERIS Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults.1

UCERIS is now available for patients through the public drug plans of five Canadian provinces: Ontario, Quebec, Saskatchewan, New Brunswick and Nova Scotia.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×